Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis

Background and objectivesLong lasting immune response to anti-SARS-CoV-2 vaccination in people with Multiple Sclerosis (pwMS) is still largely unexplored. Our study aimed at evaluating the persistence of the elicited amount of neutralizing antibodies (Ab), their activity and T cell response after th...

Full description

Bibliographic Details
Main Authors: Alessandro Maglione, Rachele Francese, Irene Arduino, Rachele Rosso, Manuela Matta, Simona Rolla, David Lembo, Marinella Clerico
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
anti-SARS-CoV-2 vaccination
multiple sclerosis
COVID-19
neutralizing antibodies
T-cell response
disease modifying therapies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205879/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205879/full

Similar Items